title: Don't jump to rash conclusions.
authors.affiliation: Translational Research Laboratory, Medical Oncologist, Tom Baker Cancer Centre and University of Calgary, Alberta, Canada. Gwyn.Bebb@albertahealthservices.ca
authors.forename: Gwyn
authors.initials: G
authors.lastname: Bebb
authors.forename: William
authors.initials: W
authors.lastname: Boland
authors.forename: Barbara
authors.initials: B
authors.lastname: Melosky
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D066246:ErbB Receptors / Q000037:antagonists & inhibitors*; D005076:Exanthema / Q000139:chemically induced*; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; C501466:nimotuzumab; D066246:ErbB Receptors